Loading clinical trials...

Arthroscopic Treatment for Femoral Acetabular Impingement Syndrome With Gluteus Medius Lesions. | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT04951180

Arthroscopic Treatment for Femoral Acetabular Impingement Syndrome With Gluteus Medius Lesions.

To evaluate the prognosis of femoral acetabular impingement syndrome (FAIS) patients with gluteus medius lesions after hip arthroscopy.

Lead sponsor: Peking University Third Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jian-quan Wang, M.D.

CONTACT

+8613801076267 [email protected]

Related studies

Not Yet Recruiting

'Do Patient Characteristics Associate With Poor Outcome With FAIS Following Physiotherapy-led Rehabilitation'

NCT07460401 · Femoral Acetabular Impingement

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 7, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment150

Start dateMay 2021

Last updatedJul 7, 2021

Condition

Femoral Acetabular Impingement

Locations shown

Peking University Third Hospital

Beijing

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 7, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions